Cargando…

PD-L1(+) lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients

INTRODUCTION: Cancer stem cells (CSCs) are implicated in tumor initiation and development of metastasis. However, whether CSCs also affect the immune system is not fully understood. We investigated correlations between the PD-L1(+) CSCs, changes in T-cell phenotype in metastatic and non-metastatic l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raniszewska, A., Vroman, H., Dumoulin, D., Cornelissen, R., Aerts, J. G. J. V., Domagała-Kulawik, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889682/ https://www.ncbi.nlm.nih.gov/pubmed/32808188 http://dx.doi.org/10.1007/s00262-020-02648-y

Ejemplares similares

Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
por: Raniszewska, Agata, et al.
Publicado: (2020)

Effector Memory T Cells and CD45RO+ Regulatory T Cells in Metastatic vs. Non-Metastatic Lymph Nodes in Lung Cancer Patients
por: Kwiecień, Iwona, et al.
Publicado: (2022)

Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry
por: Kwiecień, Iwona, et al.
Publicado: (2021)

How to evaluate the immune status of lung cancer patients before immunotherapy
por: Domagala-Kulawik, Joanna, et al.
Publicado: (2017)

Lung Cancer Stem Cells—Origin, Diagnostic Techniques and Perspective for Therapies
por: Raniszewska, Agata, et al.
Publicado: (2021)

Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy
por: Domagala-Kulawik, Joanna, et al.
Publicado: (2017)

Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
por: Kwiecień, Iwona, et al.
Publicado: (2021)

Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response
por: Kwiecien, Iwona, et al.
Publicado: (2019)

Clinicopathological and Immunomicroenvironment Characteristics of Epstein–Barr Virus-Associated Gastric Cancer in a Chinese Population
por: Jia, Xiaoxia, et al.
Publicado: (2021)

P01 LACTATE TRAFFICKING INHIBITION RESTORES SENSITIVITY TO PROTEASOME INHIBITHORS AND ORCHESTRATES IMMUNOMICROENVIRONMENT IN MULTIPLE MYELOMA
por: Giallongo, C., et al.
Publicado: (2023)

Blood Monocyte Subsets with Activation Markers in Relation with Macrophages in Non-Small Cell Lung Cancer
por: Kwiecień, Iwona, et al.
Publicado: (2020)

Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC
por: Agrawal, Vishesh, et al.
Publicado: (2017)

Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma
por: van Gulijk, Mandy, et al.
Publicado: (2022)

Systematic lymph node sampling at operation results in more node positive staging in NSCLC
por: Whiteley, J, et al.
Publicado: (2015)

Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas
por: Wang, Jinchao, et al.
Publicado: (2023)

Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging
por: Sha, Xue, et al.
Publicado: (2020)

Lymphography in Metastatic Lymph Node Disease
por: Burn, J. I., et al.
Publicado: (1965)

Size of Metastatic Lymph Nodes
por: Uriev, L., et al.
Publicado: (2013)

Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
por: Yuan, Chenxi, et al.
Publicado: (2019)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Flow Cytometric Analysis of Macrophages and Cytokines Profile in the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer
por: Kwiecień, Iwona, et al.
Publicado: (2023)

Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes
por: Borm, Frank J., et al.
Publicado: (2023)

Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC
por: Ding, Nan, et al.
Publicado: (2017)

Role of lymph node yield and lymph node ratio in predicting outcomes in non‐metastatic colorectal cancer
por: Lee, C. H. A., et al.
Publicado: (2018)

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma
por: Minnema-Luiting, Jorien, et al.
Publicado: (2018)

Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
por: van Deurzen, Carolien H. M., et al.
Publicado: (2008)

Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma
por: Zheng, Chuan-Ming, et al.
Publicado: (2018)

Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer
por: Gao, Peng, et al.
Publicado: (2012)

Importance of Metastatic Lymph Node Ratio in Non-Metastatic, Lymph Node-Invaded Colon Cancer: A Clinical Trial
por: Isik, Arda, et al.
Publicado: (2014)

Mesenchymal stem cells empower T cells in the lymph nodes via MCP-1/PD-L1 axis
por: He, Yifan, et al.
Publicado: (2022)

Occult lymph node metastasis is not a favorable factor for resected NSCLC patients
por: Cai, Jing-Sheng, et al.
Publicado: (2023)

T Lymphocyte Maturation Profile in the EBUS-TBNA Lymph Node Depending on the DLCO Parameter in Patients with Pulmonary Sarcoidosis
por: Rutkowska, Elżbieta, et al.
Publicado: (2021)

Prostate Cancer Metastatic to the Cervical Lymph Nodes
por: Sepúlveda, Luis, et al.
Publicado: (2015)

PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer
por: Seifert, Adrian M., et al.
Publicado: (2020)

Evaluation of new classifications of N descriptor in non-small cell lung cancer (NSCLC) based on the number and the ratio of metastatic lymph nodes
por: Pawełczyk, Konrad, et al.
Publicado: (2016)

New Frontiers for Molecular Pathology
por: Domagala-Kulawik, Joanna
Publicado: (2019)

The clinico-pathological characteristics of surgically treated young women with NSCLC
por: Trojnar, Anna, et al.
Publicado: (2022)

A case of cervical lymph node tuberculosis and metastatic squamous cell carcinoma in the same lymph node
por: Uchida, Yoshinori, et al.
Publicado: (2021)

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
por: Emprou, Camille, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9uva49pp9d37u55ms4vp4kbe4i